Zobrazeno 1 - 10
of 28
pro vyhledávání: ''
Autor:
Adrian Gheorghe, Arnie Purushotham, Ajay Aggarwal, James Spice, Richard Sullivan, Bernard Rachet, Kalipso Chalkidou, Camille Maringe
Publikováno v:
European Journal of Cancer
INTRODUCTION: Delays in cancer diagnosis arose from the commencement of non-pharmaceutical interventions (NPI) introduced in the UK in March 2020 in response to the COVID-19 pandemic. Our earlier work predicted this will lead to approximately 3620 av
Publikováno v:
European Journal of Cancer
Autor:
Sergio Marchini, Gian Antonio Da Prada, Paolo Pedrazzoli, Vittoria Fotia, Francesco Moccia, Matteo G. Della Porta, Maurizio D'Incalci, Alberto Zambelli, Elisa Bonetti, Alberto Riccardi, Luca Beltrame, Vittorio Rosti, Richard Tancredi, Camillo Porta, Valentina Poletto, Giulia Gallizzi
Publikováno v:
European Journal of Cancer. 77:155-164
Background Neovascularisation supports the metastatic switch in many aggressive solid cancers. Tumour neovessels are mostly lined by endothelial cells sprouting from nearby capillaries, but they could also be contributed by circulating endothelial pr
Publikováno v:
European Journal of Cancer. 51:2655-2664
Background Bacterial dysbiosis was previously described in human malignancies. In a recent animal model, tumour susceptibility was transmitted using faecal transplantation. Our aim was to evaluate possible association between antibiotic exposure and
Autor:
Petra Rosado-Varela, Macarena González-Guerrero, Patricia Ramírez-Daffós, Inmaculada Expósito-Álvarez, Esperanza Arriola-Arellano, Cristina Cortés-Carmona, E. Benítez-Rodríguez, María C. Díaz-Blanco, Antonio Rueda-Ramos, José Manuel Baena-Cañada, Lourdes Solana-Grimaldi, Sara Estalella-Mendoza
Publikováno v:
European Journal of Cancer. 48:3328-3334
Aim of the study The authors analyse the effect of chemotherapy on the use of additional health-care resources and report the clinical and demographic factors associated with such use. Patients and methods In women with breast cancer, eligible to rec
Autor:
M, Kaufmann, N, Maass, S D, Costa, A, Schneeweiss, S, Loibl, M W, Sütterlin, I, Schrader, B, Gerber, W, Bauer, W, Wiest, O, Tomé, A, Distelrath, V, Hagen, A, Kleine-Tebbe, E, Ruckhaeberle, K, Mehta, G, von Minckwitz, C, Karg
Publikováno v:
European Journal of Cancer. 46:3184-3191
To determine activity and safety of capecitabine at a moderate dose of 2000 mg/m(2) as first-line therapy for metastatic breast cancer.In this prospective phase II trial, patients with HER2-negative metastatic breast cancer received first-line capeci
Autor:
Henrik Brønnum-Hansen, Jan J. Barendregt, Gerda Engholm, Isabelle Soerjomataram, Hans H. Storm, Esther de Vries, Georg Paludan-Müller
Publikováno v:
European Journal of Cancer, 46(14), 2617-2624. Elsevier Ltd.
Soerjomataram, I, de Vries, E, Engholm, G, Paludan-Müller, G, Brønnum-Hansen, H, Storm, H H & Barendregt, J J 2010, ' Impact of a smoking and alcohol intervention programme on lung and breast cancer incidence in Denmark: An example of dynamic modelling with Prevent ', European journal of cancer (Oxford, England : 1990), vol. 46, no. 14, pp. 2617-24 . https://doi.org/10.1016/j.ejca.2010.07.051
Soerjomataram, I, de Vries, E, Engholm, G, Paludan-Müller, G, Brønnum-Hansen, H, Storm, H H & Barendregt, J J 2010, ' Impact of a smoking and alcohol intervention programme on lung and breast cancer incidence in Denmark: An example of dynamic modelling with Prevent ', European journal of cancer (Oxford, England : 1990), vol. 46, no. 14, pp. 2617-24 . https://doi.org/10.1016/j.ejca.2010.07.051
Purpose: Among the known risk factors, smoking is clearly related to the incidence of lung cancer and alcohol consumption to breast cancer. In this manuscript we modeled the potential benefits of reductions in smoking or alcohol prevalence for the bu
Autor:
Jean-Charles Soria, Claire Aerts, Gerd Munzert, Stefan Sleijfer, Jean-Pascal Machiels, Jan Bogaerts, Etienne Brain, Holger Fritsch, Gertraud Hanft, Christel Fontaine, Jérôme Rapion, Isabelle Ray-Coquard, Anouk Allgeier, Denis Lacombe, Pascal Wolter, Patrick Schöffski, Jean-Yves Blay, Jacques De Greve
Publikováno v:
European Journal of Cancer, 46(12), 2206-2215. Elsevier Ltd.
Aims: BI 2536 is a selective and potent small-molecule inhibitor of polo-like kinase 1. We performed a multi-centre, multi-tumour phase II trial to investigate the efficacy, safety and pharmacokinetics of BI 2536 in five solid tumour types. Patients
Autor:
Orhan Sezer, Jackson S.Y. Wu, Liying Zhang, Mark Clemons, Albert Yee, Edward Chow, Michael Barton, Richard Eek, Galina Velikova, Andrea Bezjak, Michael Brundage, Andrew Bottomley, Kristin Harris, Yvette M. van der Linden, Jesmin Shafiq, Peter Hoskin, Colin D. Johnson
Publikováno v:
European Journal of Cancer. 45:2510-2518
The objective of this study was to examine the agreement between health care professionals' (HCPs) and patients' evaluation of health-related quality of life (HRQOL) issues for cancer patients with bone metastases. A total of 413 patients and 152 HCP
Publikováno v:
European Journal of Cancer. 44:269-274
The aim was to assess the effect of geographical accessibility on the stage of cancer at diagnosis and survival. Records of 117,097 cases of breast, colorectal, lung, ovary and prostate cancer diagnosed in Northern England between 1994 and 2002 were